Jacobs Levy Equity Management, Inc Esperion Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.84 - $3.24 $200,709 - $353,422	-109,081 Reduced 15.49%	595,016 $1.32 Million
Q1 2024 May 15, 2024	SELL	$2.02 - $3.02 $714,649 - $1.07 Million	-353,787 Reduced 33.44%	704,097 $1.89 Million
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $880,726 - $3.72 Million	-1,206,475 Reduced 53.28%	1,057,884 $3.16 Million
Q3 2023 Nov 16, 2023	BUY	$0.96 - $1.79 $1.76 Million - $3.29 Million	1,836,567 Added 429.31%	2,264,359 $2.22 Million
Q2 2023 Aug 14, 2023	BUY	$1.2 - $1.76 $326,746 - $479,228	272,289 Added 175.1%	427,792 $594,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $13,846 - $69,233	9,484 Added 6.5%	155,503 $247,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $743,236 - $1.24 Million	146,019 New	146,019 $909,000
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $881,008 - $1.29 Million	-35,072 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $2,904 - $4,291	120 Added 0.34%	35,072 $912,000
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $114,368 - $193,340	-3,668 Reduced 9.5%	34,952 $1.3 Million
Q2 2020 Aug 17, 2020	BUY	$30.04 - $51.31 $13,848 - $23,653	461 Added 1.21%	38,620 $1.98 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $84,734 - $228,017	-3,088 Reduced 7.49%	38,159 $1.2 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $316,369 - $534,611	8,937 Added 27.66%	41,247 $2.46 Million
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $43,432 - $59,887	1,260 Added 4.06%	32,310 $1.18 Million
Q2 2019 Aug 13, 2019	SELL	$40.1 - $52.33 $26,867 - $35,061	-670 Reduced 2.11%	31,050 $1.44 Million
Q1 2019 May 14, 2019	BUY	$40.11 - $53.57 $945,392 - $1.26 Million	23,570 Added 289.2%	31,720 $1.27 Million
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $11,097 - $17,733	300 Added 3.82%	8,150 $375,000
Q3 2018 Nov 14, 2018	BUY	$40.74 - $51.41 $319,809 - $403,568	7,850 New	7,850 $348,000

Others Institutions Holding ESPR

# of Institutions

206

Shares Held

129M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $147M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account